Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Preclinical CRO Market?

The market size of preclinical Contract Research Organizations (CRO) has seen significant expansion in the past years. From a worth of $5.7 billion in 2024, it’s projected to increase to $6.26 billion in 2025, representing a compound annual growth rate (CAGR) of 9.9%. The surge in this historical period can be linked to a growing demand for hastened drug development, cost containment tactics, emphasis on core skills, regulatory compliance mandates, and the internationalization of clinical trials.

What Growth Rate Is Forecasted for the Preclinical CRO Market by 2029?

Expectations are high for substantial growth in the preclinical CRO market over the coming years, with predictions suggesting it could reach $9.06 billion by 2029, representing a compound annual growth rate (CAGR) of 9.7%. This predicted growth within the specified period could be the result of several factors including an increased focus on personalized medicine, rare diseases and orphan drugs, a rise in outsourcing within the biopharmaceutical industry, emphasis on biomarker research, and a growing demand for real-world evidence generation. Key trends likely to be seen during this forecast period include the application of artificial intelligence (AI), expansion of oncology research, advancements in omics technologies, evolution of in vitro and in vivo models, and increased collaborative efforts for translational research.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10303&type=smp

Which Key Companies Are Shaping the Future of the Preclinical CRO Market?

Major companies operating in the preclinical CRO market include Eurofins Scientific SE, PRA Health Sciences Inc., Wuxi AppTec Co. Ltd., Medpace Holdings Inc., Charles River Laboratories International Inc., Laboratory Corporation of America Holdings, SGA SA, Intertek Group plc, Crown Bioscience International, Cynbiose, AmplifyBio LLC, Vivotecnia SL, Simavita Ltd., BioEmission Technology Solutions, Altasciences Company Inc., Global Center For Medical Innovation, Pharmaceutical Product Development LLC, Parexel International Corporation, Envigo RMS Holding Corporation, Veeda Clinical Research Ltd., ICON plc, Kunming Biomed International Ltd., PharmaLegacy Laboratories, NorthEast BioAnalytical Laboratories LLC, MDS Pharma Services, MPI Research, Toxikon Corporation, BioReliance Corporation, Covance Inc., Syngene International Limited

Which Factors Are Driving Demand in the Preclinical CRO Industry?

The preclinical CRO market is forecasted to experience a surge due to the rising need for preclinical trials. Preclinical trials, which involve studies performed on treatments or drugs before they are tested on human participants, are crucial in drug development. They typically involve innovative medical devices, prescription drugs, and diagnostics. The primary aims being, determining an initial, safe dose for initial human research and examining any potential toxicity of the product. Given the escalating focus on the safety and efficacy of new drugs, the significance of preclinical trials is on the rise. For example, clinical development productivity reports by IQVIA, a US-based company dealing with health information technology and clinical research industries, indicated a rise in 2023. The data showed that 69 novel active substances (NASs) were launched worldwide in 2023, a climb from the preceding year by 6, and the US saw 24 premier launches. Consequently, the burgeoning need for preclinical trials propels the forward movement of the preclinical CRO market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10303&type=smp

How Is the Preclinical CRO Market Segmented by Several Divisions?

The preclinical CRO market covered in this report is segmented –

1) By Service: Bioanalysis And DMPK Studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Others Services

2) By Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model

3) By Animal Model: Small Animal Model, Large Animal Model

4) By Model System: In Vivo, In Vitro

5) By End User: Biopharmaceutical Companies, Government And Academic Institutes, Medical Device Companies, Other End-users

Subsegments:

1) By Bioanalysis And DMPK Studies: Pharmacokinetics Studies, Pharmacodynamics Studies, Drug Metabolism Studies

2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Reproductive Toxicity Testing

3) By Compound Management: Sample Management, Inventory Management, Formulation Services

4) By Chemistry: Medicinal Chemistry, Analytical Chemistry, Synthetic Chemistry

5) By Safety Pharmacology: Cardiovascular Safety Studies, Central Nervous System Safety Studies, Respiratory Safety Studies

6) By Other Services: Regulatory Consulting, Project Management, Data Management Services

What are the Emerging Market Trends Driving the Growth of the Preclinical CRO Industry?

The preclinical CRO market is presently witnessing a trend of increasing popularity in technological advancements. To remain competitive in this market, leading companies are embracing cutting-edge technologies. BenchSci, an AI solutions firm for preclinical R&D from Canada, for example, unveiled its SaaS (software as a service) platform, ASCEND, designed for preclinical drug discovery in February 2023. The main aim of this system is to expedite the drug development pipelines in the preclinical phase by providing biological insights into the foundational principles of diseases. BenchSci’s machine-learning technology is utilized by ASCEND to extract experimental data from secure internal and public external sources. The platform then evaluates these experimental findings against curated ontology datasets. This enables the software to generate a map of the biological processes at the root of a variety of diseases, supported by evidence.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/preclinical-cro-global-market-report

Which Regions Are Driving Growth in the Preclinical CRO Market?

North America was the largest region in the preclinical CRO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global preclinical CRO market during the forecast period. The regions covered in the preclinical CRO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10303

This Report Delivers Insight On:

1. How big is the preclinical cro market, and how is it changing globally?

2. Who are the major companies in the preclinical cro market, and how are they performing?

3. What are the key opportunities and risks in the preclinical cro market right now?

4. Which products or customer segments are growing the most in the preclinical cro market?

5. What factors are helping or slowing down the growth of the preclinical cro market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model